{
  "claim_id": "claim_002",
  "claim": "Cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
  "document": "CDC_Influenza_vaccines",
  "additional_evidence_check": {
    "checked_for_more": true,
    "found_additional": false,
    "additional_count": 0
  },
  "completeness_stats": {
    "existing_evidence": 1,
    "new_evidence_found": 0,
    "total_evidence": 1
  },
  "combined_evidence": [
    {
      "id": 1,
      "quote": "that any influenza vaccine (egg based or non egg based) that is otherwise appropriate for the recipient's age and health status can be used (see Persons with a History of Egg Allergy).",
      "relevance_explanation": "This quote distinguishes between egg-based and non-egg-based (cell-based or recombinant) influenza vaccines, which is relevant context for discussing differences in production, including the potential for mutations. However, it does not directly address mutations or effectiveness."
    }
  ],
  "completeness_assessment": {
    "missing_aspects": []
  },
  "model_used": "gpt-4.1"
}